Search
Xininurad
go.drugbank.com/drugs/DB21564ExperimentalXininurad is a small molecule drug. The usage of the INN stem '-inurad' in the name indicates that Xininurad is a urate transporter inhibitor. … Xininurad has a monoisotopic molecular weight of 440.91 Da.
Ansornitinib
go.drugbank.com/drugs/DB21577ExperimentalAnsornitinib is a small molecule drug. The usage of the INN stem '-tinib' in the name indicates that Ansornitinib is a tyrosine kinase inhibitor. … Ansornitinib has a monoisotopic molecular weight of 540.25 Da.
Garsorasib
go.drugbank.com/drugs/DB21581InvestigationalGarsorasib is a small molecule drug. The usage of the INN stem '-rasib' in the name indicates that Garsorasib is a Ras protein inhibitor. Garsorasib has a monoisotopic molecular weight of 598.26 Da.
Gumelutamide
go.drugbank.com/drugs/DB21615ExperimentalGumelutamide is a small molecule drug. The usage of the INN stem '-lutamide' in the name indicates that Gumelutamide is a non-steroid antiandrogen. … Gumelutamide has a monoisotopic molecular weight of 420.15 Da.
Frevecitinib
go.drugbank.com/drugs/DB21681InvestigationalFrevecitinib is a small molecule drug. The usage of the INN stem '-citinib' in the name indicates that Frevecitinib is a Janus kinase inhibitor. … Frevecitinib has a monoisotopic molecular weight of 415.18 Da.
Odentegravir
go.drugbank.com/drugs/DB21708ExperimentalOdentegravir is a small molecule drug. The usage of the INN stem '-tegravir' in the name indicates that Odentegravir is a HIV integrase inhibitor. … Odentegravir has a monoisotopic molecular weight of 421.12 Da.
Amredobresib
go.drugbank.com/drugs/DB21566InvestigationalAmredobresib is under investigation in clinical trial NCT02516553 (BI 894999 First in Human Dose Finding Study in Advanced Malignancies). Amredobresib has a monoisotopic molecular weight of 467.25 Da. … Amredobresib is a small molecule drug.
Tegtociclib
go.drugbank.com/drugs/DB21635InvestigationalTegtociclib is a small molecule drug. The usage of the INN stem '-ciclib' in the name indicates that Tegtociclib is a cyclin dependant kinase inhibitor. … Tegtociclib is under investigation in clinical trial NCT05262400 (A Study to Learn About the Study Medicine (Called PF-07220060 in Combination With PF-07104091) In Participants With Breast Cancer and Solid
AT1022
go.drugbank.com/drugs/DB04995ExperimentalAT1022 is a hydromorphone skin patch designed to provide rapid and sustained delivery of a potent opiate for the management of severe pain.
Ketobemidone
go.drugbank.com/drugs/DB06738InvestigationalKetobemidone is a powerful opioid analgesic. It also has some NMDA-antagonist properties. This makes it useful for some types of pain that don't respond well to other opioids. … The most commonly cited equalisation ratio for analgesic doses is 25 mg of ketobemidone hydrobromide to 60 mg of morphine hydrochloride or sulfate and circa 8 mg of ketobemidone by injection.